Clinical Trials Browser

Solid Tumors × tocilizumab × 90 days × Clear all

NCT03448042 2026-05-28

A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors